Florida Attorney General files lawsuit against Pfizer over COVID‑19 vaccine marketing
On October 1, 2026, Florida Attorney General James Uthmeier sued Pfizer Inc. and its chief executive Albert Bourla, accusing the company of deceptive promotion of its COVID‑19 vaccine. The complaint alleges that Pfizer downplayed serious side‑effects such as myocarditis and pericarditis in children and potential complications for pregnant women. The filing also references more than $10 billion spent on vaccine advertising between 2020 and 2023 and highlights Bourla’s compensation of roughly $102 million during that period.
Why it matters
The suit could pressure Pfizer’s brand and expose the firm to litigation costs, which investors may view as a downside risk. The Florida AG’s office indicated that the case could affect the company’s financial results if damages are awarded or if marketing practices are forced to change.
Key facts
- 1The complaint was lodged on October 1, 2026 by Florida Attorney General James Uthmeier. marketscreener.com
- 2Pfizer and its CEO Albert Bourla are named as defendants in the lawsuit. gurufocus.com
- 3The allegation centers on claims that the company concealed risks of myocarditis and pericarditis in minors and possible adverse effects for pregnant women. gurufocus.com
- 4Pfizer reportedly spent over $10 billion on vaccine advertising from 2020 through 2023. gurufocus.com
- 5Albert Bourla’s compensation for the same period is said to be about $102 million. gurufocus.com
- 6Pfizer’s dividend yield is 6.19% with a payout ratio of 71%. gurufocus.com
Summary written by AlphAI from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.